Flagship Harbor Advisors, LLC Takeda Pharmaceutical CO LTD Transaction History

Flagship Harbor Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$15.39 - $18.97 $7,833 - $9,655	-509 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$17.1 - $19.19 $6,053 - $6,793	-354 Reduced 41.02%	509 $9,000
Q2 2020 Jul 31, 2020	BUY	$14.59 - $19.5 $3,866 - $5,167	265 Added 44.31%	863 $15,000
Q1 2020 May 12, 2020	BUY	$13.02 - $20.31 $1,953 - $3,046	150 Added 33.48%	598 $9,000
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $101 - $124	6 Added 1.36%	448 $9,000
Q3 2019 Oct 22, 2019	SELL	$16.15 - $17.99 $1,518 - $1,691	-94 Reduced 17.54%	442 $7,000
Q2 2019 Jul 22, 2019	BUY	$16.58 - $20.49 $762 - $942	46 Added 9.39%	536 $9,000
Q1 2019 Apr 15, 2019	BUY	$16.7 - $21.52 $8,183 - $10,544	490 New	490 $10,000

318

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $46.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.